23 Jan Overview of FDA Regulations on Human Cell and Tissue Based Products: 351 vs. 361 Classification
Disclaimer: I’m not an attorney, this is not legal advice. Overview With the exponential increase in the United States for regenerative procedures over the past decade, there has also been a major rise in regulatory questions. These questions revolve around autologous vs allogeneic regulations, cellular vs acellular...